Antimicrobial Use-Related Problems Among Hospitalized Pediatric Patients: A Prospective Observational Study

Kidu Gidey1, Solomon Girmay Aregawi1, Berhane Yohannes Hailu1

  • 1Department of Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.

PubMed

Insights

Over half of hospitalized pediatric patients experienced antimicrobial use-related problems, including unnecessary or additional therapy. Comorbidities and longer hospital stays increased these risks, highlighting the need for better antimicrobial stewardship.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Infectious Diseases

Background:

  • Antimicrobial misuse is a global health concern, contributing to antimicrobial resistance.
  • Limited data exists on antimicrobial use-related problems in pediatric populations, particularly in developing nations.

Purpose of the Study:

  • To determine the prevalence of antimicrobial use-related problems in hospitalized pediatric patients.
  • To identify risk factors associated with these problems in pediatric patients.

Main Methods:

  • A prospective observational study was conducted at Ayder Comprehensive Specialized Hospital in Ethiopia.
  • Included pediatric patients (≤15 years) admitted with infectious diseases between September and November 2019.
  • Data collected on patient demographics, diagnoses, and antimicrobial therapy to identify use-related problems.

Main Results:

  • A total of 232 pediatric patients were enrolled; 53.9% experienced at least one antimicrobial use-related problem.
  • The most frequent problems were unnecessary antimicrobial therapy (22.8%) and the need for additional antimicrobial therapy (16.4%).
  • Comorbidities (AOR: 1.84) and hospital stays over one week (AOR: 1.88) were significant predictors of these problems.

Conclusions:

  • Antimicrobial use-related problems are prevalent in hospitalized pediatric patients in this setting.
  • Interventions should focus on targeted education, antimicrobial stewardship, and responsible prescribing practices.
  • Enhanced pediatric care and collaborative efforts are crucial to mitigate these issues.
Abstract